Rheumatoid Arthritis Nosode is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Adenosine Triphosphate Disodium; Malic Acid; Sodium Diethyl Oxalacetate; Orotic Acid Monohydrate; Riboflavin; Apiole (parsley); Cinnamic Acid; Prasterone; Streptococcus Viridans Group; Borrelia Burgdorferi; Brucella Abortus; Oyster Shell Calcium Carbonate, Crude; Campylobacter Jejuni; Chlamydia Trachomatis; Klebsiella Pneumoniae; Mycoplasma Pneumoniae; Yersinia Enterocolitica; Streptococcus Pneumoniae; Streptococcus Agalactiae; Enterococcus Faecalis; Streptococcus Mutans; Salmonella Enterica Subsp. Enterica Serovar Enteritidis; Shigella Dysenteriae; Shigella Sonnei; Streptococcus Dysgalactiae; Streptococcus Uberis; Proteus Morganii; Streptococcus Equinus.
Product ID | 43742-0492_38bbd8c7-7a40-4e57-872b-5229d417c266 |
NDC | 43742-0492 |
Product Type | Human Otc Drug |
Proprietary Name | Rheumatoid Arthritis Nosode |
Generic Name | Adenosinum Triphosphoricum Dinatrum, Malic Acid, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Apiolum, Cinnamic Acid, Dhea (dehydroepiandrosterone), Streptococcus Viridans, Borrelia Burgdorferi Nosode, Brucella Abortus, Calcarea Carbonica, Campylobacter Jejuni, Chlamydia Trachomatis, Klebsiella Pheumoniae, Mycoplasma Pneumoniae, Yersinia Enterocolitica, Pneumococcinum, Streptococcus Agalactiae, Enterococcus Faecalis, Streptococcus Mutans, Salmonella Enteritidis, Dysentery Bacillus, Shigella Sonnei |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2014-06-21 |
Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
Labeler Name | Deseret Biologicals, Inc. |
Substance Name | ADENOSINE TRIPHOSPHATE DISODIUM; MALIC ACID; SODIUM DIETHYL OXALACETATE; OROTIC ACID MONOHYDRATE; RIBOFLAVIN; APIOLE (PARSLEY); CINNAMIC ACID; PRASTERONE; STREPTOCOCCUS VIRIDANS GROUP; BORRELIA BURGDORFERI; BRUCELLA ABORTUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; CAMPYLOBACTER JEJUNI; CHLAMYDIA TRACHOMATIS; KLEBSIELLA PNEUMONIAE; MYCOPLASMA PNEUMONIAE; YERSINIA ENTEROCOLITICA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS AGALACTIAE; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS MUTANS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS UBERIS; PROTEUS MORGANII; STREPTOCOCCUS EQUINUS |
Active Ingredient Strength | 6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-06-21 |
Marketing End Date | 2022-11-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved homeopathic |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2014-06-21 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
ADENOSINE TRIPHOSPHATE DISODIUM | 6 [hp_X]/mL |
SPL SET ID: | 01f30680-cb54-4c07-a9a6-847b453770a5 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
43742-0434 | Rheumatoid Arthritis Nosode | ATP (Adenosine Triphosphate Disodium), Malic Acid, Natrum Oxalaceticum, Riboflavinum, Apiolum, Cinnamic Acid, DHEA (Dehydroepiandrosterone), Streptococcus viridans |
43742-0492 | Rheumatoid Arthritis Nosode | Adenosinum Triphosphoricum Dinatrum, Malic Acid, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Apiolum, Cinnamic Acid, DHEA (Dehydroepiandrosterone), Streptococcus Viridans, Borrelia Burgdorferi Nosode, Brucella Abortus, Calcarea Carbonica, Campylobacter Jejuni, Chlamydia Trachomatis, Klebsiella Pheumoniae, Mycoplasma Pneumoniae, Yersinia Enterocolitica, Pneumococcinum, Streptococcus Agalactiae, Enterococcus Faecalis, Streptococcus Mutans, Salmonella Enteritidis, Dysentery Bacillus, Shigella Sonnei |